The Relationship Between Finger Ratio and Development in Infants

May 4, 2026 updated by: Rabia ZORLULAR, Nigde Omer Halisdemir University

The Relationship Between Digit Ratio and Motor Development and Sensory Processing in Infants

One of the most prominent indicators of prenatal androgen exposure is considered to be the ratio of second and fourth finger lengths (2D:4D). The 2D:4D finger ratio refers to the ratio of the length of the second finger (2D; index finger) and the fourth finger (4D; ring finger). Evidence suggests that 2D:4D is developmentally stable and stabilizes from the second trimester of pregnancy. It has been reported that the 2D:4D ratio correlates positively with estrogen and negatively with testosterone. In both sexes, prenatal testosterone levels are inversely related by a 2D:4D ratio, which does not change with age. Androgens can have direct trophic effects on target cells or indirectly affect neuronal growth through neurotrophic mediators released locally by steroid-sensitive neuronal or glial cells. Prenatal testosterone can have long-term organizational effects on the structure and function of various body systems (e.g., cardiovascular and musculoskeletal systems) that are important for physical activity and exercise.

Study Overview

Detailed Description

One of the most prominent indicators of prenatal androgen exposure is considered to be the ratio of second and fourth finger lengths (2D:4D). The 2D:4D finger ratio refers to the ratio of the length of the second finger (2D; index finger) and the fourth finger (4D; ring finger). Evidence suggests that 2D:4D is developmentally stable and stabilizes from the second trimester of pregnancy. It has been reported that the 2D:4D ratio correlates positively with estrogen and negatively with testosterone. In both sexes, prenatal testosterone levels are inversely related by a 2D:4D ratio, which does not change with age.

From a gender perspective, differences have been found in the basic motor skills of boys and girls. Boys have greater object control skills than girls. Gender is one of the most studied variables in motor development. Many longitudinal studies show that boys perform better in gross motor skills such as running and jumping, while girls are more successful in fine motor tasks such as drawing or manipulating small objects. Sensory processing involves the capacity to receive, interpret, organize, and respond to sensory input from both one's own body and the external environment. Sensory processing disorders can be observed in infants due to the immaturity of their systems. There are very few studies on measuring finger length in the early stages of newborns. To our knowledge, the relationship between intrauterine androgen exposure (2D:4D) and motor development and sensory processing has not yet been investigated. Therefore, the planned study aims to evaluate the 2D:4D finger ratio in 12-18-month-old infants and to examine the relationship between this ratio and motor development and sensory processing.

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study will include healthy, full-term (37-40 weeks of gestation) infants aged 12 to 18 months.

Description

Inclusion Criteria:

  • Term infants (37-40 weeks),
  • Infants aged 12-18 months

Exclusion Criteria:

  • Preterm infants,
  • Infants with congenital infections or proven genetic changes,
  • Infants and mothers diagnosed with metabolic, neurological, and genetic diseases,
  • Maternal diabetes,
  • Intrauterine growth retardation,
  • Infants with a history of hand-related surgery,
  • Children whose parents did not volunteer to study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy infants
Healthy, full-term (37-40 weeks of gestation) infants aged 12 to 18 months and their families will be invited to participate in the study.
The lengths of the second (2D) and fourth (4D) fingers will be measured separately on each hand. Measurements will be taken with the baby's hands placed flat on a surface with palms facing upwards. Finger length will be defined as the distance from the midpoint of the proximal crease at the base of the finger to the distal end of the finger. A digital caliper with a precision of 0.01 mm will be used, and two separate measurements will be taken for each finger, with the average value recorded. Based on these measurements, the 2D:4D finger ratio for each hand will be calculated by dividing the length of the second finger by the length of the fourth finger.
The Peabody Developmental Motor Scale-2 (PDMS-2) is planned to be used to assess motor development. The PDMS-2 test is designed to identify developmental delays in children aged 0-72 months. It is used to evaluate children's motor development with separate tests and rating scales for both gross and fine motor skills.
The Test of Sensory Functions in Infants was planned for use to assess babies' sensory development. The TSFI is frequently used to evaluate the sensory processing functions of infants aged 4-18 months. It is used to determine whether and to what extent a baby has a sensory processing problem. It consists of 24 items. The TSFI requires the baby to be stimulated and interact with various materials. The total score ranges from 0-49, and the test has normative values for different age groups. Although it can be used from the fourth month onwards, the most reliable and valid results are obtained between 7-18 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Digit Ratio
Time Frame: 12-18 months
The lengths of the second (2D) and fourth (4D) fingers of the participants will be measured separately on each hand. Measurements will be taken with the participants' hands placed flat on a surface with the palms facing upwards. Measurements will be performed using a digital caliper with a precision of 0.01 mm, two separate measurements will be taken for each finger, and the average value will be recorded. Based on the obtained measurements, the 2D:4D finger ratio will be calculated by dividing the 2D length by the 4D length on both hands. To increase the reliability of the measurements, the assessments will be performed twice by a researcher who is blind to motor development and sensory processing skills.
12-18 months
Sensory processing
Time Frame: 12-18 months
The Test of Sensory Functions in Infants is a standardized assessment tool designed to evaluate sensory processing abilities in infants aged 4 to 18 months. The TSFI examines responses across multiple sensory domains, including tactile, vestibular, visual, and oral-motor functions, providing a comprehensive profile of an infant's sensory processing. In the tactile deep pressure response section, it is scored as 0: reverse response, 1: mild defensive response, and 2: integrated response. In the adaptive motor response section, it is scored as 0: no response, 1: disorganized, 2: partial, 3: organized. In the visual-tactile integration section, it is scored as 0: hyperactive, 1: hyporeactive, and 2: normal. The oculomotor test section is scored as 0: no response or poorly integrated, 1: well integrated. Response to vestibular stimulation is scored as 0: adverse response, 1: mild defensive response, and 2: integrated response. The total score ranges from 0 to 49.
12-18 months
Motor development
Time Frame: 12-18 months
The Peabody Developmental Motor Scales, Second Edition, is a standardized tool used to assess gross and fine motor skills in children from birth to 5 years of age. The assessment comprises six subtests: reflexes, stationary, locomotion, object manipulation, grasping, and visual-motor integration, which together provide a comprehensive evaluation of a child's motor development. It has been widely validated in both typically developing children and those with various developmental disorders, making it a reliable and widely used instrument in pediatric motor assessment. Items are scored with 0, 1, and 2 points. When the child performs the item according to the specified item criteria, 2 points are given. One point is awarded when the behavior occurs, but the criteria for successful performance are not fully met. A score of 0 is given when the child is unable to try the item or does not reveal any skills when he tries it. Results are expressed as raw, standard, or total motor scores.
12-18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rabia ZORLULAR, Nigde Omer Halisdemir University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

April 6, 2026

First Submitted That Met QC Criteria

April 6, 2026

First Posted (Actual)

April 13, 2026

Study Record Updates

Last Update Posted (Actual)

May 8, 2026

Last Update Submitted That Met QC Criteria

May 4, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant Developmental Assessment

Clinical Trials on Digit Ratio

Subscribe